Sema4 Holdings Corp. (NASDAQ:SMFR – Get Rating) major shareholder Tactical Opportunit Blackstone bought 2,500,000 shares of Sema4 stock in a transaction dated Friday, April 29th. The shares were acquired at an average price of $4.00 per share, with a total value of $10,000,000.00. Following the completion of the purchase, the insider now directly owns 26,839,187 shares in the company, valued at approximately $107,356,748. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
SMFR opened at $2.15 on Wednesday. The business has a fifty day simple moving average of $2.80 and a 200 day simple moving average of $4.43. Sema4 Holdings Corp. has a 1 year low of $2.10 and a 1 year high of $15.21. The company has a debt-to-equity ratio of 0.08, a quick ratio of 4.44 and a current ratio of 4.77.
Sema4 (NASDAQ:SMFR – Get Rating) last released its quarterly earnings results on Monday, March 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.22) by $0.05. The firm had revenue of $57.80 million during the quarter, compared to the consensus estimate of $50.90 million. As a group, sell-side analysts anticipate that Sema4 Holdings Corp. will post -0.8 EPS for the current year.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Royal Bank of Canada acquired a new position in Sema4 in the 3rd quarter valued at $36,000. Citigroup Inc. acquired a new position in Sema4 in the 3rd quarter valued at $79,000. Victory Capital Management Inc. acquired a new position in Sema4 in the 3rd quarter valued at $88,000. CIBC Asset Management Inc acquired a new position in Sema4 in the 4th quarter valued at $56,000. Finally, Tudor Investment Corp Et Al acquired a new position in Sema4 in the 3rd quarter valued at $106,000.
Sema4 Company Profile (Get Rating)
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services.
- Get a free copy of the StockNews.com research report on Sema4 (SMFR)
- There Are Weeds In The Garden At Scotts Miracle-Gro
- It’s Time For FuboTV to Stand Out in the Sea of Streaming
- 3M Stock is Worth a Look Because of the Company it Keeps
- Landstar Systems Stock Can Bottom Down Here
- 3 Attractive Mid Cap Swing Trades
Receive News & Ratings for Sema4 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sema4 and related companies with MarketBeat.com's FREE daily email newsletter.